- Interests
- Bone Marrow Diseases
- Immune System Disorders
- Allergic Diseases
- Autoimmune Diseases
- Rheumatic Diseases
- Interests
- Bone Marrow Diseases
- Immune System Disorders
- Allergic Diseases
- Autoimmune Diseases
- Rheumatic Diseases
Academic Background
Education and Specialization
1981 - Atatürk University Faculty of Medicine
1989 - Gülhane Military Medical Academy
1993 - Ankara University Faculty of Medicine
Experience
1981-1989 - Gülhane Military Medical Academy and Military Medical Academy Infectious Diseases and Clinical Microbiology Department
1989-1990 - Marshal Fevzi Çakmak Military Hospital, Infectious Diseases
1990-1993 - Ankara University Faculty of Medicine, Department of Immunology
1993-2008 - Gülhane Military Medical Academy and Military Medical Academy, Head of Immunology Department
2008-2019 - Medical Park Antalya
2020-2023 - MEDICANA International Istanbul Hospital
Read moreEducation and Specialization
1981 - Atatürk University Faculty of Medicine
1989 - Gülhane Military Medical Academy
1993 - Ankara University Faculty of Medicine
Experience
1981-1989 - Gülhane Military Medical Academy and Military Medical Academy Infectious Diseases and Clinical Microbiology Department
1989-1990 - Marshal Fevzi Çakmak Military Hospital, Infectious Diseases
1990-1993 - Ankara University Faculty of Medicine, Department of Immunology
1993-2008 - Gülhane Military Medical Academy and Military Medical Academy, Head of Immunology Department
2008-2019 - Medical Park Antalya
2020-2023 - MEDICANA International Istanbul Hospital
Scientific Publications
Scientific Publications
1. Results of Real-time Multiplex Polymerase Chain Reaction Assay in Renal Transplant Recipients With Sterile Pyuria. Sarier M, Demir M, Goktas S, Duman I, Buyukkinaci M, Yuksel Y, Tekin S, Yavuz AH, Sengul A. Transplant Proc. 2017 Jul - Aug;49(6):1307-1311. doi: 10.1016/j.transproceed.2017.02.051.
2. Post-transplantation Malignancy After Kidney Transplantation in Turkey. Keles Y, Tekin S, Duzenli M, Yuksel Y, Yücetin L, Dosemeci L, Sengul A, Demirbaş A, Tuncer M. Transplant Proc. 2015 Jun;47(5):1418-20. doi: 10.1016/j.transproceed.2015.04.010.
3. First International Paired Exchange Kidney Transplantations of Turkey. Tuncer M, Tekin S, Yuksel Y, Yücetin L, Dosemeci L, Sengul A, Demirbaş A. Transplant Proc. 2015 Jun;47(5):1294-5. doi: 10.1016/j.transproceed.2015.04.011.
4. Immunosuppressive effects of multipotent mesenchymal stromal cells on graft-versus-host disease in rats following allogeneic bone marrow transplantation. Nevruz O, Avcu F, Ural AU, Pekel A, Dirican B, Safalı M, Akdağ E, Beyzadeoğlu M, Ide T, Sengül A. Turk J Haematol. 2013 Sep;30(3):256-62. doi: 10.4274/Tjh.2013.0032. Epub 2013 Sep 5
5. Immunocompetent cell level as a diagnostic reference for pulpal pathosis of primary teeth. Durutürk L, Sarı S, Sengül A. Arch Oral Biol. 2013 Oct;58(10):1517-22. doi: 10.1016/j.archoralbio.2013.04.010. Epub 2013 May 20.
6. The role of human leukocyte antigen tissue groups in hepatitis B virus vaccination in Turkey. Mert G, Sengul A, Gul HC, Karakas A, Eyigun CP. J Microbiol Immunol Infect. 2014 Feb;47(1):9-14. doi: 10.1016/j.jmii.2013.01.004. Epub 2013 Mar 21
7. Hepatitis B surface antigen positivity is not a contraindication for living kidney donation. Tuncer M, Tekin S, Yücetin L, Şengül A, Demirbaş A. Transplant Proc. 2012 Jul-Aug;44(6):1628-9. doi: 10.1016/j.transproceed.2012.04.015.
8. Comparison of paired exchange kidney transplantations with living related kidney transplantations. Tuncer M, Tekin S, Yücetin L, Şengül A, Demirbas A. Transplant Proc. 2012 Jul-Aug;44(6):1626-7. doi: 10.1016/j.transproceed.2012.05.045.
9. Tissue leptin levels in patients with breast cancer. Karaduman M, Bilici A, Ozet A, Sengul A, Musabak U, Alomeroglu M. J BUON. 2010 Apr-Jun;15(2):369-72
10. [Prognostic value of serum TNF-alpha, IL-10, leptin and CRP levels in newborns with septicemia]. Cesur S, Irmak H, Eras Z, Yaşar H, Sengül A, Dilmen U, Demiröz AP, Biyikli Z, Ilikçi R. Mikrobiyol Bul. 2009 Oct;43(4):607-12.
11. IL-18 promoter polymorphisms confer susceptibility to Behçet's disease, particularly to the mucocutaneous form, in a Turkish population. Keskin F, Pay S, Musabak U, Sagkan RI, Erdem H, Simsek I, Kose O, Dinc A, Sengul A.
Clin Exp Rheumatol. 2009 Mar-Apr;27(2 Suppl 53):S108-9.
12. Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.
Keskin G, Inal A, Keskin D, Pekel A, Baysal O, Dizer U, Sengül A. Protein Pept Lett. 2008;15(3):314-7
13. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, Sanisoglu SY, Yesilova Z, Ozmenler N, Ozsahin A, Sengul A. Clin Dev Immunol. 2007;2007:76396
14. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A. Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S70-5
15. Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization? Pay S, Simsek I, Erdem H, Pekel A, Musabak U, Sengul A, Dinc A. Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S34-40.
16. Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis? Pay S, Musabak U, Simsek I, Erdem H, Pekel A, Sengul A, Dinc A. Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S21-6.
17. Tissue levels of adiponectin in breast cancer patients. Karaduman M, Bilici A, Ozet A, Sengul A, Musabak U, Alomeroglu M. Med Oncol. 2007;24(4):361-6.
18. Intranasal fungi and chronic rhinosinusitis: what is the relationship? Tosun F, Hidir Y, Saracli MA, Caliskaner Z, Sengul A. Ann Otol Rhinol Laryngol. 2007 Jun;116(6):425-9
19. Phosphate enrichment and fed-batch operation for prolonged beta-lactamase production by Bacillus licheniformis. Ileri N, Calik P, Sengül A. J Appl Microbiol. 2007 May;102(5):1418-26.
20. Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis? Erdem H, Pay S, Musabak U, Simsek I, Dinc A, Pekel A, Sengul A. Rheumatol Int. 2007 Aug;27(10):969-73. Epub 2007 Jan 31.
21. Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Simsek I, Pay S, Pekel A, Dinc A, Musabak U, Erdem H, Sengul A. Rheumatol Int. 2007 Jul;27(9):807-11. Epub 2007 Jan 17
22. Expression of CXCR-1 and CXCR-2 chemokine receptors on synovial neutrophils in inflammatory arthritides: does persistent or increasing expression of CXCR-2 contribute to the chronic inflammation or erosive changes? Pay S, Musabak U, Simşek I, Pekel A, Erdem H, Dinç A, Sengül A. Joint Bone Spine. 2006 Dec;73(6):691-6. Epub 2006 Jul 18.
23. Ceftriaxone-related hemolysis and acute renal failure. Demirkaya E, Atay AA, Musabak U, Sengul A, Gok F. Pediatr Nephrol. 2006 May;21(5):733-6. Epub 2006 Feb 21.
24. Leptin, soluble interleukin-6 receptor, C-reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atherosclerotic plaque. Karaduman M, Oktenli C, Musabak U, Sengul A, Yesilova Z, Cingoz F, Olgun A, Sanisoglu SY, Baysan O, Yildiz O, Taslipinar A, Tatar H, Kutlu M, Ozata M. Clin Exp Immunol. 2006 Mar;143(3):452-7.
25. Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques. Karaduman M, Sengul A, Oktenli C, Pekel A, Yesilova Z, Musabak U, Sanisoglu SY, Gunay C, Baysan O, Kocar IH, Tatar H, Ozata M. Clin Endocrinol (Oxf). 2006 Feb;64(2):196-202.
26. Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations? Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A, Sengul A. Rheumatol Int. 2006 Apr;26(6):545-50. Epub 2005 Oct 5.
27. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis? Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A. Rheumatol Int. 2006 May;26(7):608-13. Epub 2005 Oct 5
28. Investigation of the genotype distribution of hepatitis C virus among Turkish population in Turkey and various European countries. Turhan V, Ardic N, Eyigun CP, Avci IY, Sengul A, Pahsa A. Chin Med J (Engl). 2005 Aug 20;118(16):1392-4.
29. Chimerical anti-TNF-alpha, infliximab, inhibits neutrophil chemotaxis and production of reactive oxygen species by blocking the priming effect of mononuclear cells on neutrophils. Pay S, Musabak U, Erdem H, Simsek I, Pekel A, Sengul A, Dinc A. Immunopharmacol Immunotoxicol. 2005;27(2):187-98
30. Lipid profile and anticardiolipin antibodies in Behcet's disease.
Musabak U, Baylan O, Cetin T, Yesilova Z, Sengul A, Saglam K, Inal A, Kocar IH.
Arch Med Res. 2005 Jul-Aug;36(4):387-92
31. Does immune activation continue during an attack-free period in familial Mediterranean fever?
Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, Sanisoglu SY, Inal A, Tuzun A, Erdil A, Bagci S.
Clin Exp Immunol. 2004 Dec;138(3):526-33.
32. Lack of association between Vitamin D receptor FokI polymorphism and alopecia areata.
Akar A, Orkunoglu FE, Ozata M, Sengul A, Gur AR.
Eur J Dermatol. 2004 May-Jun;14(3):156-8.
33. The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide.
Ural AU, Yilmaz MI, Avcu F, Pekel A, Zerman M, Nevruz O, Sengul A, Yalcin A.
Int J Hematol. 2003 Dec;78(5):443-9
34. Antiannexin V autoantibody in thrombophilic Behçet's disease.
Aslan H, Pay S, Gok F, Baykal Y, Yilmaz MI, Sengul A, Aydin HI.
Rheumatol Int. 2004 Mar;24(2):77-9. Epub 2003 Dec 5.
35. Gonadotropin treatment restores in vitro interleukin-1beta and tumour necrosis factor-alpha production by stimulated peripheral blood mononuclear cells from patients with idiopathic hypogonadotropic hypogonadism.
Musabak U, Bolu E, Ozata M, Oktenli C, Sengul A, Inal A, Yesilova Z, Kilciler G, Ozdemir IC, Kocar IH.
Clin Exp Immunol. 2003 May;132(2):265-70.
36. Changes in immunological recovery in patients who received post-transplant G-CSF or GM-CSF after autologous peripheral blood stem cell transplantation (PBSCT).
Arpaci F, Dogru T, Ozturk B, Komurcu S, Ozet A, Yilmaz MI, Beyzadeoglu M, Turan M, Sengul A, Yalcin A.
Haematologia (Budap). 2002;32(3):253-64
37. Increasing the target number of nucleated cells and administration of r-metHuG-CSF expedite neutrophil engraftment in allogeneic bone marrow transplantation.
Kaptan K, Ustün C, Beyan C, Ural AU, Avcu F, Cetin T, Oztürk B, Sengül A, Pekel A, Sertkaya D, Pak Y, Burgess RE, Yalçin A.
Transplant Proc. 2002 Jun;34(4):1310-4.
38. HLA class II alleles in patients with alopecia areata.
Akar A, Orkunoglu E, Sengül A, Ozata M, Gür AR.
Eur J Dermatol. 2002 May-Jun;12(3):236-9.
39. The effects of folic acid application on IL-1beta levels of human gingival fibroblasts stimulated by phenytoin and TNFalpha in vitro: a preliminary study.
Doğan A, Tunca Y, Ozdemir A, Sengül A, Imirzalioğlu N.
J Oral Sci. 2001 Dec;43(4):255-60.
40. Phagocytic activity in familial Mediterranean fever.
Keskin G, Inal A, Sengül A, Cindoruk M, Haznedaroğlu S, Duranay M, Songür Y.
Yonsei Med J. 2000 Aug;41(4):441-4.
41. The effect of testosterone replacement treatment on immunological features of patients with Klinefelter's syndrome.
Koçar IH, Yesilova Z, Ozata M, Turan M, Sengül A, Ozdemir I.
Clin Exp Immunol. 2000 Sep;121(3):448-52.
42. A successful and simplified filgrastim primed single apheresis method without large volume apheresis for peripheral blood stem cell collection.
Arpaci F, Kömürcü S, Oztürk B, Ozet A, Kinalp C, Sengül A, Beyzadeoglu M, Pak Y, Yalçin A.
Jpn J Clin Oncol. 2000 Mar;30(3):153-8
43. The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism.
Yesilova Z, Ozata M, Kocar IH, Turan M, Pekel A, Sengul A, Ozdemír IC.
J Clin Endocrinol Metab. 2000 Jan;85(1):66-70.
44. Serum IFN-gamma and IL-10 levels before and after specific immunotherapy in patients with allergic rhinitis.
Keskin G, Inal A, Ali Sari R, Sengül A, Sahin M, Turgay M, Kinikli G.
Allergol Immunopathol (Madr). 1999 Sep-Oct;27(5):261-4.
45. İmmune status of individuals with differing clinical courses of HBV infection.
Eyigün CP, Avci IY, Sengül A, Hacibektasoglu A, Van Thiel DH.
Hepatogastroenterology. 1999 May-Jun;46(27):1890-4.
46. A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and PreS subunit vaccine for immunization of healthy adults.
Eyigün CP, Yilmaz S, Gül C, Sengül A, Hacibektasoglu A, Van Thiel DH.
J Viral Hepat. 1998 Jul;5(4):265-9.
47. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
Ozata M, Bulur M, Beyhan Z, Sengül A, Saglam M, Turan M, Corakci A, Ali Gundogan M.
Endocr J. 1997 Oct;44(5):719-24.
48. Soluble intercellular adhesion molecule-1 concentrations in patients with subacute thyroiditis and in patients with Graves' disease with or without ophthalmopathy.
Ozata M, Bolu E, Sengül A, Altinsoy HI, Turan M, Corakci A, Hacibektasoglu A, Gundogan MA.
Endocr J. 1996 Oct;43(5):517-25
49. Effects of octreotide treatment on Graves' ophthalmopathy and circulating sICAM-1 levels.
Ozata M, Bolu E, Sengul A, Tasar M, Beyhan Z, Corakci A, Gundogan MA.
Thyroid. 1996 Aug;6(4):283-8.
50. Antisperm antibody and Klinefelter syndrome: does autoimmunity play a role in the pathogenesis?
Sengül A, Gül D, Sayli BS, Hacibektaşoğlu A.
Urol Int. 1996;57(2):77-9.
51. [HIV infections among Turkish citizens who have lived in foreign countries].
Demiröz P, Irmak H, Sengül A, Ceviz HA, Kocabalkan F.
Mikrobiyol Bul. 1989 Jul;23(3):203-9.
52. The determination of complement activation in patients with mucocutaneous Behçet's disease
U.0lmez, A. Sengul, M. Turgay, G. Tokgoz, H. Tutkak, N. Duzgun, A. Gurler, M. Duman
La Revue de Médecine Interne, 14(1): 121 1993
53. Tumor necrosis factor-alpha and interleukin-6 levels in Behçet's disease
A. Sengul, H. Tutkak, N. Tulek, K. Ozoran, N. Duzgun, A. Gurler, G. Tokgoz
La Revue de Médecine Interne, 14(1): 120 1993
54. A new modality in cancer therapy: Antisense inhibition of gene expression.
U Muşabak, A Şengül, A İnal, Y Akcan International Journal of Hematology and Oncology 28 (4): 106-114 2001
55. Cellular Immune Response A ŞENGÜL Turkiye Klinikleri Journal of Infection Diseases-Special Topics 1 (2),19 2008
56. Assessment of phagocytes and oxidative burst functions of monocytes and granulocytes in 15 patients with bronchiectasis
A Ertürk, S Canbakan, M Gülhan, E Ünsal, A Şengül, A Pekel, N Çapan Eurasian Journal of Pulmonology 9 (2), 93-98 2007
57. Neopterin levels in differential diagnosis of active and inactive pulmonary tuberculosis
A Yeğen, S Yurt, N Işık, N Yaman, B Arpınar Yiğitbaş, H Uzun, AF Koşar Eurasian Journal of Pulmonology 9 (2), 64-74 2007
58. Sayı Editöründen
A ŞENGÜL, Y BAYKAL
Turkiye Klinikleri Journal of Internal Medical Sciences 3 (8), 0-0 2007
59. Transplantasyonda HLA ve Non-HLA Antijenler
A ŞENGÜL
Turkiye Klinikleri Journal of Internal Medical Sciences 3 (8), 1-6 2007
60. Expression des récepteurs de chimiokines CXCR-1 et CXCR-2 sur les neutrophiles synoviaux dans les arthrites inflammatoires: une expression persistante ou croissante de CXCR2
S Pay, U Musabak, İ Şimşek, A Pekel, H Erdem, A Dinç, A Şengül
Revue du rhumatisme 73 (12), 1358-1363 2006
61. Immune Reconstution After Allogeneic Bone Marrow Transplantation in Early Posttransplant Period
T DOĞRU, F ARPACI, B ÖZTÜRK, AU URAL, A Ferit, A SÖNMEZ, .. A Şengül.
International Journal of Hematology and Oncology 28 (4), 009-017 2006
62. İntravenöz İmmünglobulin (İVİG) Tedavisi
U MUŞABAK, A ŞENGÜL, L KENAR
Turkiye Klinikleri Journal of Immunology Rheumatology 3 (2), 107-116 2003
63. Kronik Hepatit B'li Olgulardaİnterferon-Alfa+ LamivudinKombine Tedavisinin Etkinliği ve Güvenilirliği
HC GÜL, CP EYİGÜN, V TURHAN, AB BEŞİRBELLİOĞLU, A ŞENGÜL, ...
Turkiye Klinikleri Journal of Gastroenterohepatology 11 (3), 141-148 2000
64. New Approaches to Therapy of Insulin Dependent Diabetes Mellitus
B Ersoy, Z Beyhan, M Bulur, M Özata, A Şengül, M Sağlam, M Turan, ...
Turkish Journal of Endocrinology and Metabolism 1 (2), 053-061 1997
65. Serum Prostate Specific Antigen Levels in Male Hypogonadism
Z Beyhan, M Bulur, M Özata, A Şengül, M Sağlam, M Turan, ME Önde, ...
Turkish Journal of Endocrinology and Metabolism 1 (2), 062-065 1997
66. Role of the Major Histocompatibliity Complex in the Genetics of Human Leukemia
MT Dorak, M YILDIRIMKAYA, NK NAZAROĞLU, A ŞENGÜL, Y NARİN, ...
TURKISH JOURNAL OF MEDICAL SCIENCES 26, 119-124 1996
67. Ketotifen'in Allerji Deri Testlerine Etkisi
M KARAAYVAZ, V KÖSEOĞLU, Y BAYKAL, A ŞENGÜL, N OZANGÜÇ
Turkiye Klinikleri Journal of Medical Sciences 15 (4), 241-243 1995
68. Geç tip aşırı duyarlılığın değerlendirilmesinde tetanoz toksoidinin önemi
A Hacıbektaşoğlu, A Şengül, A Pahsa, F Kocabalkan, P Demiröz
Gaziantep University Gaziantep Medical Journal 1990
69. Romatoid Artrit ve Osteoartritli Hastaların Plazma ve Sinovyal Sıvılarında C5a Düzeyi
D KESKİN, G KESKİN, A İNAL, A ŞENGÜL
Turkiye Klinikleri Journal of Medical Sciences 28 (2), 133-136 2008
70. Göbek kordonu kanındaki kök hücre, lenfosit ve lenfosit alt gruplarının immünfenotipik olarak belirlenmesi
B Türkmen, O Gürsel, AA Atay, AE Kürekçi, V Köseoğlu, E Kısmet, A Şengül
Gülhane Tıp Dergisi 2008; 50: 261-266 2008
71. IL-10 and IL-13 production by peripheral blood mononuclear cells in patients with diabetes mellitus
A Inal, U Muşabak, G Keskin, L Özsari, A Şengül, M Kutlu, Ç Öktenli
Turkish Journal of Medical Sciences 38 (1), 43-48 2008
72. Serum and synovial fluid C5a levels in patients with rheumatoid arthritis and Osteoarthritis
D Keskin, G Keskin, A Inal, A Sengul
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI 28 (2), 133-136 2008
73. CA XII expression study in HT 29 colon carcinoma cell line upon cytokine TNF-alpha and TGF-beta stimulations
RI Sagkan, F Kockar, A Sengul
FEBS JOURNAL 275, 125-125 2008
74. Humoral Immune Reactions and Evaluation Methods for Solid Organ Transplantations
A ŞENGÜL
Turkiye Klinikleri Journal of Hematology-Oncology Special Topics 2 (1), 7-11 2009
75. Secondary Immunodeficiencies
A ŞENGÜL
Turkiye Klinikleri Journal of Immunology Rheumatology-Special Topics 3 (3), 103 2010
76. Diyalize Başlanmamış Kronik Böbrek Yetmezliklerde Antikardiyolipin Antikor Sıklığı
F BULUCU, A VURAL, Z YEŞİLOVA, A ŞENGÜL, M YENİCESU, Y OĞUZ
O.M.Ü. Tıp Dergisi 15 (3) 216-220 1998
77. Specific Polymorphisms of IL-1 [Beta] Genes (-511,+ 3953) and Their Probable Effects on IL-1 [Beta] Production in Idiopatic Hypogonadotropic Hypogonadism/Idiopatik
U Musabak, E Bolu, RI Sagkan, Y Tunca, S Güran, D Gül, A Sengül
Türkiye Klinikleri. Tip Bilimleri Dergisi 30 (6), 1814 2010
78. Transplantasyon İmmünolojisi
A ŞENGÜL
Turkiye Klinikleri Urology-Special Topics 4 (3), 1-9 2011
79. Analysis of tumor associated transmembrane enzyme CAIX in HT-29 cells by flow cytometry
Rİ Sağkan, F Köçkar, A Şengül, S Yılmaz, UH Müsabak
FEBS Journal 278 (Suppl. 1) 211 2011
80. Solid Organ ve Kompozit Doku Nakillerinde İmmün Baskının İzlenmesi
A ŞENGÜL
Turkiye Klinikleri Immunology Allergy-Special Topics 10 (1), 29-34 2017
81. Fekal Mikrobiyota Transplantasyonu: Endikasyonlar ve Uygulamalar
A ŞENGÜL
Turkiye Klinikleri Immunology Allergy-Special Topics 11 (2), 129-134 2018
82.THE IMUNOLOJICAL IDENTIFICATION OF PAI-1 (PLASMİNOGEN ACTİVATOR INHİBİTOR-1) ON HUMAN BREAST CANCER TİSUE AND NORMAL MAMMARY GLAND
Mehmet Karaduman, Ahmet Özet, Ali Şengül
Endocrine Practice: January 2016, Vol. 22, No. 1, pp. 17-18.
83.THE IMUNOLOJICAL IDENTIFICATION OF LEPTIN ON HUMAN BREAST CANCER TISSUE AND NORMAL MAMMARY GLAND
Bahattin Aydın, Mehmet Karaduman, Ahmet Özet, Ali Şengül
ENDOCRINE PRACTICE Vol 22 No. 1pp.18- January 2016
84.THE IMMUNOLOJICAL IDENTIFICATION OF ADIPONECTIN LEVELS ON HUMAN BREAST CANCER TİSSUE AND NORMAL MAMMARY GLAND
Mehmet Karaduman, Ahmet Özet, Ali Şengül
Endocr Pract. 2014;20(No. 1) 24-25
85. ANALYSIS OF HLA CLASS I AND CLASS II ALLELES IN HEALTHY INDIVIDUALS OFTURKISH POPULATION.
Ali Sengul, Sema Oren, Rahsan Ilikci, Ali Inal, Ugur Musabak.
Human Immunology 2008 69: Suppl1Page 95
Scientific Publications
1. Results of Real-time Multiplex Polymerase Chain Reaction Assay in Renal Transplant Recipients With Sterile Pyuria. Sarier M, Demir M, Goktas S, Duman I, Buyukkinaci M, Yuksel Y, Tekin S, Yavuz AH, Sengul A. Transplant Proc. 2017 Jul - Aug;49(6):1307-1311. doi: 10.1016/j.transproceed.2017.02.051.
2. Post-transplantation Malignancy After Kidney Transplantation in Turkey. Keles Y, Tekin S, Duzenli M, Yuksel Y, Yücetin L, Dosemeci L, Sengul A, Demirbaş A, Tuncer M. Transplant Proc. 2015 Jun;47(5):1418-20. doi: 10.1016/j.transproceed.2015.04.010.
3. First International Paired Exchange Kidney Transplantations of Turkey. Tuncer M, Tekin S, Yuksel Y, Yücetin L, Dosemeci L, Sengul A, Demirbaş A. Transplant Proc. 2015 Jun;47(5):1294-5. doi: 10.1016/j.transproceed.2015.04.011.
4. Immunosuppressive effects of multipotent mesenchymal stromal cells on graft-versus-host disease in rats following allogeneic bone marrow transplantation. Nevruz O, Avcu F, Ural AU, Pekel A, Dirican B, Safalı M, Akdağ E, Beyzadeoğlu M, Ide T, Sengül A. Turk J Haematol. 2013 Sep;30(3):256-62. doi: 10.4274/Tjh.2013.0032. Epub 2013 Sep 5
5. Immunocompetent cell level as a diagnostic reference for pulpal pathosis of primary teeth. Durutürk L, Sarı S, Sengül A. Arch Oral Biol. 2013 Oct;58(10):1517-22. doi: 10.1016/j.archoralbio.2013.04.010. Epub 2013 May 20.
6. The role of human leukocyte antigen tissue groups in hepatitis B virus vaccination in Turkey. Mert G, Sengul A, Gul HC, Karakas A, Eyigun CP. J Microbiol Immunol Infect. 2014 Feb;47(1):9-14. doi: 10.1016/j.jmii.2013.01.004. Epub 2013 Mar 21
7. Hepatitis B surface antigen positivity is not a contraindication for living kidney donation. Tuncer M, Tekin S, Yücetin L, Şengül A, Demirbaş A. Transplant Proc. 2012 Jul-Aug;44(6):1628-9. doi: 10.1016/j.transproceed.2012.04.015.
8. Comparison of paired exchange kidney transplantations with living related kidney transplantations. Tuncer M, Tekin S, Yücetin L, Şengül A, Demirbas A. Transplant Proc. 2012 Jul-Aug;44(6):1626-7. doi: 10.1016/j.transproceed.2012.05.045.
9. Tissue leptin levels in patients with breast cancer. Karaduman M, Bilici A, Ozet A, Sengul A, Musabak U, Alomeroglu M. J BUON. 2010 Apr-Jun;15(2):369-72
10. [Prognostic value of serum TNF-alpha, IL-10, leptin and CRP levels in newborns with septicemia]. Cesur S, Irmak H, Eras Z, Yaşar H, Sengül A, Dilmen U, Demiröz AP, Biyikli Z, Ilikçi R. Mikrobiyol Bul. 2009 Oct;43(4):607-12.
11. IL-18 promoter polymorphisms confer susceptibility to Behçet's disease, particularly to the mucocutaneous form, in a Turkish population. Keskin F, Pay S, Musabak U, Sagkan RI, Erdem H, Simsek I, Kose O, Dinc A, Sengul A.
Clin Exp Rheumatol. 2009 Mar-Apr;27(2 Suppl 53):S108-9.
12. Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.
Keskin G, Inal A, Keskin D, Pekel A, Baysal O, Dizer U, Sengül A. Protein Pept Lett. 2008;15(3):314-7
13. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, Sanisoglu SY, Yesilova Z, Ozmenler N, Ozsahin A, Sengul A. Clin Dev Immunol. 2007;2007:76396
14. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A. Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S70-5
15. Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization? Pay S, Simsek I, Erdem H, Pekel A, Musabak U, Sengul A, Dinc A. Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S34-40.
16. Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis? Pay S, Musabak U, Simsek I, Erdem H, Pekel A, Sengul A, Dinc A. Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S21-6.
17. Tissue levels of adiponectin in breast cancer patients. Karaduman M, Bilici A, Ozet A, Sengul A, Musabak U, Alomeroglu M. Med Oncol. 2007;24(4):361-6.
18. Intranasal fungi and chronic rhinosinusitis: what is the relationship? Tosun F, Hidir Y, Saracli MA, Caliskaner Z, Sengul A. Ann Otol Rhinol Laryngol. 2007 Jun;116(6):425-9
19. Phosphate enrichment and fed-batch operation for prolonged beta-lactamase production by Bacillus licheniformis. Ileri N, Calik P, Sengül A. J Appl Microbiol. 2007 May;102(5):1418-26.
20. Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis? Erdem H, Pay S, Musabak U, Simsek I, Dinc A, Pekel A, Sengul A. Rheumatol Int. 2007 Aug;27(10):969-73. Epub 2007 Jan 31.
21. Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Simsek I, Pay S, Pekel A, Dinc A, Musabak U, Erdem H, Sengul A. Rheumatol Int. 2007 Jul;27(9):807-11. Epub 2007 Jan 17
22. Expression of CXCR-1 and CXCR-2 chemokine receptors on synovial neutrophils in inflammatory arthritides: does persistent or increasing expression of CXCR-2 contribute to the chronic inflammation or erosive changes? Pay S, Musabak U, Simşek I, Pekel A, Erdem H, Dinç A, Sengül A. Joint Bone Spine. 2006 Dec;73(6):691-6. Epub 2006 Jul 18.
23. Ceftriaxone-related hemolysis and acute renal failure. Demirkaya E, Atay AA, Musabak U, Sengul A, Gok F. Pediatr Nephrol. 2006 May;21(5):733-6. Epub 2006 Feb 21.
24. Leptin, soluble interleukin-6 receptor, C-reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atherosclerotic plaque. Karaduman M, Oktenli C, Musabak U, Sengul A, Yesilova Z, Cingoz F, Olgun A, Sanisoglu SY, Baysan O, Yildiz O, Taslipinar A, Tatar H, Kutlu M, Ozata M. Clin Exp Immunol. 2006 Mar;143(3):452-7.
25. Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques. Karaduman M, Sengul A, Oktenli C, Pekel A, Yesilova Z, Musabak U, Sanisoglu SY, Gunay C, Baysan O, Kocar IH, Tatar H, Ozata M. Clin Endocrinol (Oxf). 2006 Feb;64(2):196-202.
26. Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations? Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A, Sengul A. Rheumatol Int. 2006 Apr;26(6):545-50. Epub 2005 Oct 5.
27. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis? Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A. Rheumatol Int. 2006 May;26(7):608-13. Epub 2005 Oct 5
28. Investigation of the genotype distribution of hepatitis C virus among Turkish population in Turkey and various European countries. Turhan V, Ardic N, Eyigun CP, Avci IY, Sengul A, Pahsa A. Chin Med J (Engl). 2005 Aug 20;118(16):1392-4.
29. Chimerical anti-TNF-alpha, infliximab, inhibits neutrophil chemotaxis and production of reactive oxygen species by blocking the priming effect of mononuclear cells on neutrophils. Pay S, Musabak U, Erdem H, Simsek I, Pekel A, Sengul A, Dinc A. Immunopharmacol Immunotoxicol. 2005;27(2):187-98
30. Lipid profile and anticardiolipin antibodies in Behcet's disease.
Musabak U, Baylan O, Cetin T, Yesilova Z, Sengul A, Saglam K, Inal A, Kocar IH.
Arch Med Res. 2005 Jul-Aug;36(4):387-92
31. Does immune activation continue during an attack-free period in familial Mediterranean fever?
Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, Sanisoglu SY, Inal A, Tuzun A, Erdil A, Bagci S.
Clin Exp Immunol. 2004 Dec;138(3):526-33.
32. Lack of association between Vitamin D receptor FokI polymorphism and alopecia areata.
Akar A, Orkunoglu FE, Ozata M, Sengul A, Gur AR.
Eur J Dermatol. 2004 May-Jun;14(3):156-8.
33. The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide.
Ural AU, Yilmaz MI, Avcu F, Pekel A, Zerman M, Nevruz O, Sengul A, Yalcin A.
Int J Hematol. 2003 Dec;78(5):443-9
34. Antiannexin V autoantibody in thrombophilic Behçet's disease.
Aslan H, Pay S, Gok F, Baykal Y, Yilmaz MI, Sengul A, Aydin HI.
Rheumatol Int. 2004 Mar;24(2):77-9. Epub 2003 Dec 5.
35. Gonadotropin treatment restores in vitro interleukin-1beta and tumour necrosis factor-alpha production by stimulated peripheral blood mononuclear cells from patients with idiopathic hypogonadotropic hypogonadism.
Musabak U, Bolu E, Ozata M, Oktenli C, Sengul A, Inal A, Yesilova Z, Kilciler G, Ozdemir IC, Kocar IH.
Clin Exp Immunol. 2003 May;132(2):265-70.
36. Changes in immunological recovery in patients who received post-transplant G-CSF or GM-CSF after autologous peripheral blood stem cell transplantation (PBSCT).
Arpaci F, Dogru T, Ozturk B, Komurcu S, Ozet A, Yilmaz MI, Beyzadeoglu M, Turan M, Sengul A, Yalcin A.
Haematologia (Budap). 2002;32(3):253-64
37. Increasing the target number of nucleated cells and administration of r-metHuG-CSF expedite neutrophil engraftment in allogeneic bone marrow transplantation.
Kaptan K, Ustün C, Beyan C, Ural AU, Avcu F, Cetin T, Oztürk B, Sengül A, Pekel A, Sertkaya D, Pak Y, Burgess RE, Yalçin A.
Transplant Proc. 2002 Jun;34(4):1310-4.
38. HLA class II alleles in patients with alopecia areata.
Akar A, Orkunoglu E, Sengül A, Ozata M, Gür AR.
Eur J Dermatol. 2002 May-Jun;12(3):236-9.
39. The effects of folic acid application on IL-1beta levels of human gingival fibroblasts stimulated by phenytoin and TNFalpha in vitro: a preliminary study.
Doğan A, Tunca Y, Ozdemir A, Sengül A, Imirzalioğlu N.
J Oral Sci. 2001 Dec;43(4):255-60.
40. Phagocytic activity in familial Mediterranean fever.
Keskin G, Inal A, Sengül A, Cindoruk M, Haznedaroğlu S, Duranay M, Songür Y.
Yonsei Med J. 2000 Aug;41(4):441-4.
41. The effect of testosterone replacement treatment on immunological features of patients with Klinefelter's syndrome.
Koçar IH, Yesilova Z, Ozata M, Turan M, Sengül A, Ozdemir I.
Clin Exp Immunol. 2000 Sep;121(3):448-52.
42. A successful and simplified filgrastim primed single apheresis method without large volume apheresis for peripheral blood stem cell collection.
Arpaci F, Kömürcü S, Oztürk B, Ozet A, Kinalp C, Sengül A, Beyzadeoglu M, Pak Y, Yalçin A.
Jpn J Clin Oncol. 2000 Mar;30(3):153-8
43. The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism.
Yesilova Z, Ozata M, Kocar IH, Turan M, Pekel A, Sengul A, Ozdemír IC.
J Clin Endocrinol Metab. 2000 Jan;85(1):66-70.
44. Serum IFN-gamma and IL-10 levels before and after specific immunotherapy in patients with allergic rhinitis.
Keskin G, Inal A, Ali Sari R, Sengül A, Sahin M, Turgay M, Kinikli G.
Allergol Immunopathol (Madr). 1999 Sep-Oct;27(5):261-4.
45. İmmune status of individuals with differing clinical courses of HBV infection.
Eyigün CP, Avci IY, Sengül A, Hacibektasoglu A, Van Thiel DH.
Hepatogastroenterology. 1999 May-Jun;46(27):1890-4.
46. A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and PreS subunit vaccine for immunization of healthy adults.
Eyigün CP, Yilmaz S, Gül C, Sengül A, Hacibektasoglu A, Van Thiel DH.
J Viral Hepat. 1998 Jul;5(4):265-9.
47. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
Ozata M, Bulur M, Beyhan Z, Sengül A, Saglam M, Turan M, Corakci A, Ali Gundogan M.
Endocr J. 1997 Oct;44(5):719-24.
48. Soluble intercellular adhesion molecule-1 concentrations in patients with subacute thyroiditis and in patients with Graves' disease with or without ophthalmopathy.
Ozata M, Bolu E, Sengül A, Altinsoy HI, Turan M, Corakci A, Hacibektasoglu A, Gundogan MA.
Endocr J. 1996 Oct;43(5):517-25
49. Effects of octreotide treatment on Graves' ophthalmopathy and circulating sICAM-1 levels.
Ozata M, Bolu E, Sengul A, Tasar M, Beyhan Z, Corakci A, Gundogan MA.
Thyroid. 1996 Aug;6(4):283-8.
50. Antisperm antibody and Klinefelter syndrome: does autoimmunity play a role in the pathogenesis?
Sengül A, Gül D, Sayli BS, Hacibektaşoğlu A.
Urol Int. 1996;57(2):77-9.
51. [HIV infections among Turkish citizens who have lived in foreign countries].
Demiröz P, Irmak H, Sengül A, Ceviz HA, Kocabalkan F.
Mikrobiyol Bul. 1989 Jul;23(3):203-9.
52. The determination of complement activation in patients with mucocutaneous Behçet's disease
U.0lmez, A. Sengul, M. Turgay, G. Tokgoz, H. Tutkak, N. Duzgun, A. Gurler, M. Duman
La Revue de Médecine Interne, 14(1): 121 1993
53. Tumor necrosis factor-alpha and interleukin-6 levels in Behçet's disease
A. Sengul, H. Tutkak, N. Tulek, K. Ozoran, N. Duzgun, A. Gurler, G. Tokgoz
La Revue de Médecine Interne, 14(1): 120 1993
54. A new modality in cancer therapy: Antisense inhibition of gene expression.
U Muşabak, A Şengül, A İnal, Y Akcan International Journal of Hematology and Oncology 28 (4): 106-114 2001
55. Cellular Immune Response A ŞENGÜL Turkiye Klinikleri Journal of Infection Diseases-Special Topics 1 (2),19 2008
56. Assessment of phagocytes and oxidative burst functions of monocytes and granulocytes in 15 patients with bronchiectasis
A Ertürk, S Canbakan, M Gülhan, E Ünsal, A Şengül, A Pekel, N Çapan Eurasian Journal of Pulmonology 9 (2), 93-98 2007
57. Neopterin levels in differential diagnosis of active and inactive pulmonary tuberculosis
A Yeğen, S Yurt, N Işık, N Yaman, B Arpınar Yiğitbaş, H Uzun, AF Koşar Eurasian Journal of Pulmonology 9 (2), 64-74 2007
58. Sayı Editöründen
A ŞENGÜL, Y BAYKAL
Turkiye Klinikleri Journal of Internal Medical Sciences 3 (8), 0-0 2007
59. Transplantasyonda HLA ve Non-HLA Antijenler
A ŞENGÜL
Turkiye Klinikleri Journal of Internal Medical Sciences 3 (8), 1-6 2007
60. Expression des récepteurs de chimiokines CXCR-1 et CXCR-2 sur les neutrophiles synoviaux dans les arthrites inflammatoires: une expression persistante ou croissante de CXCR2
S Pay, U Musabak, İ Şimşek, A Pekel, H Erdem, A Dinç, A Şengül
Revue du rhumatisme 73 (12), 1358-1363 2006
61. Immune Reconstution After Allogeneic Bone Marrow Transplantation in Early Posttransplant Period
T DOĞRU, F ARPACI, B ÖZTÜRK, AU URAL, A Ferit, A SÖNMEZ, .. A Şengül.
International Journal of Hematology and Oncology 28 (4), 009-017 2006
62. İntravenöz İmmünglobulin (İVİG) Tedavisi
U MUŞABAK, A ŞENGÜL, L KENAR
Turkiye Klinikleri Journal of Immunology Rheumatology 3 (2), 107-116 2003
63. Kronik Hepatit B'li Olgulardaİnterferon-Alfa+ LamivudinKombine Tedavisinin Etkinliği ve Güvenilirliği
HC GÜL, CP EYİGÜN, V TURHAN, AB BEŞİRBELLİOĞLU, A ŞENGÜL, ...
Turkiye Klinikleri Journal of Gastroenterohepatology 11 (3), 141-148 2000
64. New Approaches to Therapy of Insulin Dependent Diabetes Mellitus
B Ersoy, Z Beyhan, M Bulur, M Özata, A Şengül, M Sağlam, M Turan, ...
Turkish Journal of Endocrinology and Metabolism 1 (2), 053-061 1997
65. Serum Prostate Specific Antigen Levels in Male Hypogonadism
Z Beyhan, M Bulur, M Özata, A Şengül, M Sağlam, M Turan, ME Önde, ...
Turkish Journal of Endocrinology and Metabolism 1 (2), 062-065 1997
66. Role of the Major Histocompatibliity Complex in the Genetics of Human Leukemia
MT Dorak, M YILDIRIMKAYA, NK NAZAROĞLU, A ŞENGÜL, Y NARİN, ...
TURKISH JOURNAL OF MEDICAL SCIENCES 26, 119-124 1996
67. Ketotifen'in Allerji Deri Testlerine Etkisi
M KARAAYVAZ, V KÖSEOĞLU, Y BAYKAL, A ŞENGÜL, N OZANGÜÇ
Turkiye Klinikleri Journal of Medical Sciences 15 (4), 241-243 1995
68. Geç tip aşırı duyarlılığın değerlendirilmesinde tetanoz toksoidinin önemi
A Hacıbektaşoğlu, A Şengül, A Pahsa, F Kocabalkan, P Demiröz
Gaziantep University Gaziantep Medical Journal 1990
69. Romatoid Artrit ve Osteoartritli Hastaların Plazma ve Sinovyal Sıvılarında C5a Düzeyi
D KESKİN, G KESKİN, A İNAL, A ŞENGÜL
Turkiye Klinikleri Journal of Medical Sciences 28 (2), 133-136 2008
70. Göbek kordonu kanındaki kök hücre, lenfosit ve lenfosit alt gruplarının immünfenotipik olarak belirlenmesi
B Türkmen, O Gürsel, AA Atay, AE Kürekçi, V Köseoğlu, E Kısmet, A Şengül
Gülhane Tıp Dergisi 2008; 50: 261-266 2008
71. IL-10 and IL-13 production by peripheral blood mononuclear cells in patients with diabetes mellitus
A Inal, U Muşabak, G Keskin, L Özsari, A Şengül, M Kutlu, Ç Öktenli
Turkish Journal of Medical Sciences 38 (1), 43-48 2008
72. Serum and synovial fluid C5a levels in patients with rheumatoid arthritis and Osteoarthritis
D Keskin, G Keskin, A Inal, A Sengul
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI 28 (2), 133-136 2008
73. CA XII expression study in HT 29 colon carcinoma cell line upon cytokine TNF-alpha and TGF-beta stimulations
RI Sagkan, F Kockar, A Sengul
FEBS JOURNAL 275, 125-125 2008
74. Humoral Immune Reactions and Evaluation Methods for Solid Organ Transplantations
A ŞENGÜL
Turkiye Klinikleri Journal of Hematology-Oncology Special Topics 2 (1), 7-11 2009
75. Secondary Immunodeficiencies
A ŞENGÜL
Turkiye Klinikleri Journal of Immunology Rheumatology-Special Topics 3 (3), 103 2010
76. Diyalize Başlanmamış Kronik Böbrek Yetmezliklerde Antikardiyolipin Antikor Sıklığı
F BULUCU, A VURAL, Z YEŞİLOVA, A ŞENGÜL, M YENİCESU, Y OĞUZ
O.M.Ü. Tıp Dergisi 15 (3) 216-220 1998
77. Specific Polymorphisms of IL-1 [Beta] Genes (-511,+ 3953) and Their Probable Effects on IL-1 [Beta] Production in Idiopatic Hypogonadotropic Hypogonadism/Idiopatik
U Musabak, E Bolu, RI Sagkan, Y Tunca, S Güran, D Gül, A Sengül
Türkiye Klinikleri. Tip Bilimleri Dergisi 30 (6), 1814 2010
78. Transplantasyon İmmünolojisi
A ŞENGÜL
Turkiye Klinikleri Urology-Special Topics 4 (3), 1-9 2011
79. Analysis of tumor associated transmembrane enzyme CAIX in HT-29 cells by flow cytometry
Rİ Sağkan, F Köçkar, A Şengül, S Yılmaz, UH Müsabak
FEBS Journal 278 (Suppl. 1) 211 2011
80. Solid Organ ve Kompozit Doku Nakillerinde İmmün Baskının İzlenmesi
A ŞENGÜL
Turkiye Klinikleri Immunology Allergy-Special Topics 10 (1), 29-34 2017
81. Fekal Mikrobiyota Transplantasyonu: Endikasyonlar ve Uygulamalar
A ŞENGÜL
Turkiye Klinikleri Immunology Allergy-Special Topics 11 (2), 129-134 2018
82.THE IMUNOLOJICAL IDENTIFICATION OF PAI-1 (PLASMİNOGEN ACTİVATOR INHİBİTOR-1) ON HUMAN BREAST CANCER TİSUE AND NORMAL MAMMARY GLAND
Mehmet Karaduman, Ahmet Özet, Ali Şengül
Endocrine Practice: January 2016, Vol. 22, No. 1, pp. 17-18.
83.THE IMUNOLOJICAL IDENTIFICATION OF LEPTIN ON HUMAN BREAST CANCER TISSUE AND NORMAL MAMMARY GLAND
Bahattin Aydın, Mehmet Karaduman, Ahmet Özet, Ali Şengül
ENDOCRINE PRACTICE Vol 22 No. 1pp.18- January 2016
84.THE IMMUNOLOJICAL IDENTIFICATION OF ADIPONECTIN LEVELS ON HUMAN BREAST CANCER TİSSUE AND NORMAL MAMMARY GLAND
Mehmet Karaduman, Ahmet Özet, Ali Şengül
Endocr Pract. 2014;20(No. 1) 24-25
85. ANALYSIS OF HLA CLASS I AND CLASS II ALLELES IN HEALTHY INDIVIDUALS OFTURKISH POPULATION.
Ali Sengul, Sema Oren, Rahsan Ilikci, Ali Inal, Ugur Musabak.
Human Immunology 2008 69: Suppl1Page 95
